Company Filing History:
1 out of 2,405 
1 out of 2 Years Active: 2023
Title: The Innovative Contributions of Patrick Larpent
Introduction
Patrick Larpent is a notable inventor based in Luzem, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatments. His work has led to the creation of a patent that showcases his innovative approach to drug synthesis.
Latest Patents
Larpent holds a patent for a synthetic pathway to belzutifan and crystalline phases of synthetic intermediates. This patent provides crystalline forms for certain synthetic intermediates used in the production of belzutifan, a HIF-2α inhibitor that is beneficial for cancer treatment. The disclosure also outlines processes for isolating these crystalline forms, which can enhance the efficiency of drug manufacturing.
Career Highlights
Throughout his career, Patrick Larpent has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and Werthenstein Biopharma GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Larpent has collaborated with notable professionals in his field, including Stephen M. Dalby and Clinton Scott Shultz. These collaborations have likely enriched his research and development efforts, leading to advancements in pharmaceutical sciences.
Conclusion
Patrick Larpent's contributions to the field of pharmaceuticals, particularly through his patent on belzutifan synthesis, highlight his role as an innovative inventor. His work continues to impact cancer treatment and drug development positively.